• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

WHO: Middle East respiratory syndrome coronavirus (MERS-CoV) ? Saudi Arabia (22 October 2015)

Commonground

Senior Moderator
Between 10 and 13 October 2015, the National IHR Focal Point for the Kingdom of Saudi Arabia notified WHO of 4 additional cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. The four cases are from the same compound in Riyadh city.
[h=3]Details of the cases[/h]
  • A 26-year-old, non-national female developed symptoms on 1 October and, on 8 October, was admitted to hospital. The patient, who has no comorbidities, tested positive for MERS-CoV on 9 October. Currently, she is in stable condition in a negative pressure isolation room on a ward. Investigation of history of exposure to the known risk factors in the 14 days prior to the onset of symptoms is ongoing.
  • A 27-year-old, non-national female developed symptoms on 1 October and, on 10 October, was admitted to hospital. The patient, who has no comorbidities, tested positive for MERS-CoV on 11 October. Currently, she is in stable condition in a negative pressure isolation room on a ward. The patient is a household contact of a laboratory-confirmed MERS-CoV case (see above ? case no. 1). She has no history of exposure to other known risk factors in the 14 days prior to the onset of symptoms.
  • A 26-year-old, non-national female developed symptoms on 7 October and, on 11 October, was admitted to hospital. The patient, who has no comorbidities, tested positive for MERS-CoV on 12 October. Currently, she is in stable condition in a negative pressure isolation room on a ward. The patient is a household contact of two laboratory-confirmed MERS-CoV cases (see above ? case no. 1, 2). She has no history of exposure to other known risk factors in the 14 days prior to the onset of symptoms.
  • A 26-year-old, non-national female developed symptoms on 10 October and, on 11 October, was admitted to hospital. The patient, who has no comorbidities, tested positive for MERS-CoV on 12 October. Currently, she is in stable condition in a negative pressure isolation room on a ward. The patient lives in the same area as three laboratory-confirmed MERS-CoV cases (see above ? case no. 1, 2, 3). She has no history of exposure to other known risk factors in the 14 days prior to the onset of symptoms.
Contact tracing of household and healthcare contacts is ongoing for these cases.
The National IHR Focal Point for the Kingdom of Saudi Arabia also notified WHO of the death of 3 MERS-CoV cases that were reported in previous DONs on 27 September (case no. 13), on 17 September (case no. 9) and on 2 September (case no. 1).
Globally, since September 2012, WHO has been notified of 1,599 laboratory-confirmed cases of infection with MERS-CoV, including at least 574 related deaths.

continued http://www.who.int/csr/don/22-october-2015-mers-saudi-arabia/en/
 
All 4 roomates had no cormorbidities. The 3rd becoming symptomatic 6 days after the first 2. The 4th, becoming symptomatic 9 days after the first 2.
 
Back
Top Bottom